Otsuka Holdings
VC Fund
Tokyo, Japan
Otsuka Holdings is a VC fund in Tokyo focused on Health Care and Medical. Otsuka Pharmaceutical was established in Tokushima Prefecture, Japan in 1964. At Otsuka Pharmaceutical, we are committed to a holistic approach to health and well-being of people and are striving to create innovative, thoroughly-original: pharmaceutical and nutraceutical products based on our corporate philosophy “Otsuka-people creating newproducts for better health worldwide”. Analogous to riding on a bicycle, we drive on two wheels.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Otsuka Holdings invests in
Stages Otsuka Holdings invests in
Countries Otsuka Holdings invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Round size
- Series A
- $2.1M–$26M
- Series B
- $7.1M–$13M
Investment Focus
Industry
- Health Care 8 (62%)
- Medical 3 (23%)
- Therapeutics 3 (23%)
- Biotechnology 3 (23%)
- Health Diagnostics 3 (23%)
Stage
- Series A 4 (31%)
- Series B 3 (23%)
- Funding Round 2 (15%)
- Corporate Round 2 (15%)
- Series C 1 (8%)
Country
- United States 6 (46%)
- Japan 5 (38%)
- Australia 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Roch Doliveux
CEO
|
CEO | Total investments: 0 | Find email | |
|
Busaburo Otsuka
Founder
|
Founder | Total investments: 0 | Find email | |
Debbie Profit
Vice President, OIT
|
Vice President, OIT | Total investments: 0 | Find email | |
Lisa Strouss
Director of Field Medical Digital Health
|
Director of Field Medical Digital Health | Total investments: 0 | Find email | |
Peter Zhang
Head of Biostatistics Department
|
Head of Biostatistics Department | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Vivoo
|
Vivoo is a wellness assistant that provides custom nutrition advice to the users based on their urine sample analysis.Vivoo translates the user's urine information into personalized nutrition and lifestyle advice that can easily fit in daily life. All of the Vivoo advice has been prepared by registered dieticians, nutritionists, and doctors.The company was founded in 2017 and is based in Palo Alto, California. | $13M / Series B / Jul 15, 2024 | |
VIE STYLE
|
VIE STYLE offers wearable music device and AI technology services. | $2.1M / Series A / Mar 07, 2024 | |
Atmo Biosciences
|
Atmo is a clinical stage digital health business focussed on empowering researchers, clinicians and patients with objective real-time insights into gut health and microbiome function. Atmo addresses the unmet clinical need to monitor microbiome function, allowing better diagnosis and management of personalised therapies for gastrointestinaldisorders, resulting in improved gut health and wellness. The company is underpinned by a world-first ingestible gas-sensing capsule + cloud platform, which continuously measures clinically important gaseous biomarkers during transit through the gut and transmits the data wirelessly to the cloud for aggregation and analysis, to determine gut health or dysfunction, resulting in earlier relief of symptoms through personalised therapeutic approaches. | $8M / Series B / Mar 30, 2023 | |
|
OE Therapeutics
|
OE Therapeutics provides digital therapeutics for suicide prevention. | $26M / Series A / Aug 03, 2022 | |
Oui Therapeutics
|
Oui Health is built on science shown to help people manage troubling thoughts. | $26M / Series A / Aug 02, 2022 | |
|
Vivoo
|
Vivoo is a wellness assistant that provides custom nutrition advice to the users based on their urine sample analysis.Vivoo translates the user's urine information into personalized nutrition and lifestyle advice that can easily fit in daily life. All of the Vivoo advice has been prepared by registered dieticians, nutritionists, and doctors.The company was founded in 2017 and is based in Palo Alto, California. | $6.3M / Series A / Jun 25, 2021 | |
Renascience
|
Renascience is a pharmaceuticals company. | $449.1K / Series B / Mar 11, 2019 | |
Click Therapeutics
|
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive datascience platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults. | $302M / Dec 11, 2018 | |
PeptiStar
|
PeptiStar is a CDMO (Contract Development and Manufacturing Organization) for peptide APIs, from traditional peptides to constrained peptides including macrocyclic and stapled peptides containing non-natural amino acids. PeptiStar is a technology-based company that provides its customers with high value-added services through its innovativemanufacturing technologies. | $2.8B / Corporate Round / Apr 18, 2018 | |
SomaLogic
|
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscantechnology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado. | $200M / Jan 03, 2018 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Otsuka Holdings invest in?
Otsuka Holdings invests primarily in Health Care, Medical and Therapeutics startups, most often at Series A and Series B stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Otsuka Holdings's check size?
Otsuka Holdings typically joins rounds of $2.1M–$26M at Series A and $7.1M–$13M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Otsuka Holdings participates in.
How do I contact Otsuka Holdings?
Public channels for Otsuka Holdings include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Otsuka Holdings?
The team at Otsuka Holdings includes Roch Doliveux (CEO), Busaburo Otsuka (Founder) and Debbie Profit (Vice President, OIT), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
